100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
ONS ONCC Chemo Renewal Exam 2025 Questions and Answers 2025 / 2026 (Verified Answers by Expert) $12.99
Add to cart
Quickly navigate to
Preview
  2.  
  3. ONS/ONCC
  4.  
  5. ONS/ONCC

Exam (elaborations)

ONS ONCC Chemo Renewal Exam 2025 Questions and Answers 2025 / 2026 (Verified Answers by Expert)
 1 purchase
  • Course
  • ONS/ONCC
  • Institution
  • ONS/ONCC

ONS ONCC Chemo Renewal Exam 2025 Questions and Answers 2025 / 2026 (Verified Answers by Expert) ONS ONCC Chemo Renewal Exam 2025 Questions and Answers 2025 / 2026 (Verified Answers by Expert) ONS ONCC Chemo Renewal Exam 2025 Questions and Answers 2025 / 2026 (Verified Answers by Expert)

Preview 4 out of 36  pages

Document information

  • May 30, 2024
  • 36
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers

Subjects

  • ons
  • ons oncc
  • chemo renewal exam
  • ons oncc chemo renewal exam
  • ons oncc chemo renewal exam 2025
  • ons oncc chemo renewal exam 2025 questions and ans

Written for

  • ONS/ONCC
  • ONS/ONCC

Seller

avatar-seller
NurseFerian

Reviews received

Content preview

ONS ONCC Chemo Renewal



1.Neoadjuvant therapy does not increase survival when compared to

adjuvant therapy. It only changes the timing of treatment and can change

surgical op- tions if the tumor is shrunk enough. If this occurs, the patient

may only require a lumpectomy plus radiation therapy instead of needing a

mastectomy

ANS Main benefit of neoadjuvant chemotherapy (breast cancer patient)

2.A comprehensive geriatric assessment (CGA) is a multidisciplinary

evalua- tion to assess life expectancy and risk of morbidity and mortality in

the older patient. This assessment tool would evaluate and include the

following areas

functional status, socioeconomic issues, psychosocial distress, comorbidi-

ties, cognitive function, nutritional status, polypharmacy, and a medication

review (NCCN Older Adult Oncology Guidelines, version 1.2015).

ANS Due to Mrs. Turner's age and comorbidities, her oncologist

performs a comprehensive geriatric assessment. You know that this

assessment covers all but which of the following


,3.65

ANS The NCCN Older Adult Oncology Guidelines (version 1.2015)

provides in- formation on what is included in a comprehensive geriatric

assessment. Currently, more than 60% of cancers in the United States

occur in people age and

older and as the oncology world ages, nearly half (46%) of cancer

survivors are 70 years of age or older

4.Two of the agents (docetaxel and carboplatin) that Mrs. Turner will receive

are categorized as irritants. Docetaxel can cause a significant reaction if it

extravasates. It can lead to edema, erythema, occasional pain and blister

formation (ONS Chemo/Bio guidelines, 2014). That is the most likely reason

that Mrs. Turner was given a port for her treatments. Some patients will

receive their treatments through a peripheral IV without incident. Just

because they are intravenous agents does not mean that a port is required

and needing a port has nothing to do with her being older in age. Since

none of these agents are vesicants, they likely could have been given safely

via peripheral route but having a port placed is OK as well.

ANS What is your best explanation for why Mrs. Turner was given a port

to receive her chemotherapy?



,5.Irrirtants

ANS can cause inflammation, pain, and burning but

rarely

cause tissue necrosis comparable to a vesicant (unless a large amount

or a very high concentration of the irritant is extravasated).

6.Vesicants

ANS can cause blistering and significant pain and

tissue damage and destruction, leading to tissue death.

7.Non-DNA-binding solutions remain in the local area of the

extravasation, which improves the possibility of drug deactivation.

DNA-binding agents attach to DNA nucleic acids, causing the antagonist

to be ingested cellularly, leading to progressive tissue destruction

ANS A further






, classification of an antineoplastic agent's potential to cause damage is

whether its mechanism of action includes DNA binding.

8.Bendamustinea

Dactinomycin

Daunorubicin

Doxorubicin

Epirubicin

Idarubicin

Mechlorethamine

Mitomycin

ANS DNA Binding Irritants

9.Amsacrine

Paclitaxel

Vinblastine

Vincristine

Vindesine

Vinorelbine

ANS DNA Nonbinding vessicants

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller NurseFerian. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

69052 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$12.99  1x  sold
  • (0)
Add to cart
Added